Award details

Where is the initial site of folic acid biotransformation in humans?

Reference	BBS/E/F/00043264
Principal Investigator / Supervisor	Mr Paul Finglas
Co-Investigators / Co-Supervisors
Institution	Quadram Institute Bioscience
Department	Quadram Institute Bioscience Department
Funding type	Research
Value (£)	81,400
Status	Completed
Type	Institute Project
Start date	01/07/2008
End date	30/06/2011
Duration	36 months

Abstract

Recent results and a re-appraisal of historical literature suggests, contrary to accepted wisdom, that the site of biotransformation in humans of oral physiological doses of folic acid is not the mucosal absorptive cells of the upper small intestine. Instead, folic acid is hypothesised to be passed into the hepatic portal vein (HPV) and totally cleared by the liver on 'first-pass', thus preventing any significant amount from directly entering the systemic circulation; hepatic biotransformation and subsequent enterohepatic re-circulation ensuring entry of only 5-methyltetrahydrofolic acid into the systemic blood system. However, since human liver exhibits a comparatively poor ability to reduce folic acid, a regular daily intake of physiological doses of folic acid (from a policy of mandatory fortification) could eventually result in the chronic appearance of unmetabolised folic acid in the systemic circulatory blood system, potentially inducing polar 'positive' and 'negative' effects on health. An accurate estimate of plasma 'volume-of-distribution' would allow for better estimates of the fraction of any folate test dose appearing in the systemic plasma circulation; important for further evaluations of risk-benefit analysis of the proposed folic acid fortification in the UK. The project will; (a) carry out an in vivo kinetic investigation of absorption and initial biotransformation, using stable-isotope-labelled folic acid and 5-formyltetrahydrofolic acid (a 'natural' reduced folate), in 'stable' TIPSS patients (Newcastle University); (b) extend and validate a newly developed LC-MS-MS procedure (University of Nottingham) for folate profiling in human blood fractions for the additional analysis of 13C5 stable-isotope-labelled folate forms; (c) carry out an in vivo kinetic estimation of the sampled plasma 'volume-of-distribution', using i.v administered stable-isotope-labelled 5-methyltetrahydrofolic acid, in healthy volunteers (IFR).

Summary

unavailable

Committee	Closed Committee - Animal Sciences (AS)
Research Topics	X – not assigned to a current Research Topic
Research Priority	X – Research Priority information not available
Research Initiative	X - not in an Initiative
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search